{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:32:35Z","timestamp":1761863555890},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Georgetown-Howard Universities Center for Clinical & Translational Science post-doctoral KL2 Award","award":["5KL2TR000102-04"],"award-info":[{"award-number":["5KL2TR000102-04"]}]},{"name":"Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research at the Georgetown Lombardi Comprehensive Cancer Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10549-016-3678-2","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T07:57:07Z","timestamp":1452326227000},"page":"285-293","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cardiac function in BRCA1\/2 mutation carriers with history of breast cancer treated with anthracyclines"],"prefix":"10.1007","volume":"155","author":[{"given":"Ana","family":"Barac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Lynce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihriye","family":"Mete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar M.","family":"Shara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico M.","family":"Asch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline P.","family":"Nardacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynette","family":"Wray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Herbolsheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel A.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth N.","family":"Peshkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,9]]},"reference":[{"key":"3678_CR1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333","journal-title":"J Clin Oncol"},{"key":"3678_CR2","doi-asserted-by":"crossref","first-page":"e4812","DOI":"10.1371\/journal.pone.0004812","volume":"4","author":"PL Mai","year":"2009","unstructured":"Mai PL, Chatterjee N, Hartge P et al (2009) Potential excess mortality in BRCA1\/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS ONE 4:e4812","journal-title":"PLoS ONE"},{"key":"3678_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","volume":"121","author":"J Mersch","year":"2015","unstructured":"Mersch J, Jackson MA, Park M et al (2015) Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121:269\u2013275","journal-title":"Cancer"},{"key":"3678_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2014.01.008","volume":"91","author":"M Arts-de Jong","year":"2014","unstructured":"Arts-de Jong M, Maas AH, Massuger LF, Hoogerbrugge N, de Hullu JA (2014) BRCA1\/2 mutation carriers are potentially at higher cardiovascular risk. Crit Rev Oncol Hematol 91:159\u2013171","journal-title":"Crit Rev Oncol Hematol"},{"key":"3678_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ncpcardio1452","volume":"6","author":"N Haider","year":"2009","unstructured":"Haider N, Arbustini E, Gupta S et al (2009) Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts. Nat Clin Pract Cardiovasc Med 6:250\u2013261","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"3678_CR6","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI29134","volume":"117","author":"SB Haudek","year":"2007","unstructured":"Haudek SB, Taffet GE, Schneider MD, Mann DL (2007) TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest 117:2692\u20132701","journal-title":"J Clin Invest"},{"key":"3678_CR7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","volume":"336","author":"G Olivetti","year":"1997","unstructured":"Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131\u20131141","journal-title":"N Engl J Med"},{"key":"3678_CR8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncomms1601","volume":"2","author":"PC Shukla","year":"2011","unstructured":"Shukla PC, Singh KK, Quan A et al (2011) BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun 2:593","journal-title":"Nat Commun"},{"key":"3678_CR9","doi-asserted-by":"crossref","unstructured":"Singh KK, Shukla PC, Quan A et al (2012) BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure. J Biol Chem 287:6604\u20136614","DOI":"10.1074\/jbc.M111.292664"},{"key":"3678_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jacc.2014.10.044","volume":"65","author":"W Kosmala","year":"2015","unstructured":"Kosmala W, Jellis CL, Marwick TH (2015) Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure. J Am Coll Cardiol 65:257\u2013266","journal-title":"J Am Coll Cardiol"},{"key":"3678_CR11","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63:2751\u20132768","journal-title":"J Am Coll Cardiol"},{"key":"3678_CR12","unstructured":"National Comprehensive Cancer Network (2015) Breast version 3. 2015"},{"key":"3678_CR13","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.jacc.2015.04.042","volume":"65","author":"S Kishi","year":"2015","unstructured":"Kishi S, Teixido-Tura G, Ning H et al (2015) Cumulative blood pressure in early adulthood and cardiac dysfunction in middle age: the CARDIA Study. J Am Coll Cardiol 65:2679\u20132687","journal-title":"J Am Coll Cardiol"},{"key":"3678_CR14","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.jacc.2015.04.040","volume":"65","author":"TH Marwick","year":"2015","unstructured":"Marwick TH, Venn AJ (2015) The strain of detecting early target organ damage in hypertension. J Am Coll Cardiol 65:2688\u20132690","journal-title":"J Am Coll Cardiol"},{"key":"3678_CR15","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1097\/HJH.0000000000000624","volume":"33","author":"Z Szelenyi","year":"2015","unstructured":"Szelenyi Z, Fazakas A, Szenasi G et al (2015) The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction. J Hypertens 33:1962\u20131969","journal-title":"J Hypertens"},{"key":"3678_CR16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9149(89)90496-7","volume":"64","author":"MA Hlatky","year":"1989","unstructured":"Hlatky MA, Boineau RE, Higginbotham MB et al (1989) A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 64:651\u2013654","journal-title":"Am J Cardiol"},{"key":"3678_CR17","doi-asserted-by":"crossref","first-page":"e000960","DOI":"10.1161\/JAHA.114.000960","volume":"3","author":"WH Tang","year":"2014","unstructured":"Tang WH, Topol EJ, Fan Y et al (2014) Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patients. J Am Heart Assoc 3:e000960","journal-title":"J Am Heart Assoc"},{"key":"3678_CR18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0735-1097(99)00082-0","volume":"33","author":"CN Merz","year":"1999","unstructured":"Merz CN, Kelsey SF, Pepine CJ et al (1999) The Women\u2019s Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 33:1453\u20131461","journal-title":"J Am Coll Cardiol"},{"key":"3678_CR19","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jacc.2005.03.080","volume":"47","author":"LJ Shaw","year":"2006","unstructured":"Shaw LJ, Olson MB, Kip K et al (2006) The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 47:S36\u2013S43","journal-title":"J Am Coll Cardiol"},{"issue":"1\u201339","key":"3678_CR20","first-page":"e14","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1\u201339):e14","journal-title":"J Am Soc Echocardiogr"},{"key":"3678_CR21","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1200\/JCO.2005.02.4091","volume":"23","author":"E Tan-Chiu","year":"2005","unstructured":"Tan-Chiu E, Yothers G, Romond E et al (2005) Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 23:7811\u20137819","journal-title":"J Clin Oncol"},{"key":"3678_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.echo.2012.10.008","volume":"26","author":"T Yingchoncharoen","year":"2013","unstructured":"Yingchoncharoen T, Agarwal S, Popovic ZB, Marwick TH (2013) Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr 26:185\u2013191","journal-title":"J Am Soc Echocardiogr"},{"key":"3678_CR23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/hrt.2009.173997","volume":"96","author":"E Ho","year":"2010","unstructured":"Ho E, Brown A, Barrett P et al (2010) Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 96:701\u2013707","journal-title":"Heart"},{"key":"3678_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","volume":"45","author":"LI Lin","year":"1989","unstructured":"Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255\u2013268","journal-title":"Biometrics"},{"key":"3678_CR25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307\u2013310","journal-title":"Lancet"},{"issue":"suppl","key":"3678_CR26","doi-asserted-by":"crossref","first-page":"abstr 1585","DOI":"10.1200\/jco.2012.30.15_suppl.1585","volume":"30","author":"R Ismail-Khan","year":"2012","unstructured":"Ismail-Khan R, Sajjad M, Sun W et al (2012) An exploratory study to determine if BRCA1 and BRCA2 mutation carriers have higher risk of cardiac toxicity. J Clin Oncol 30(suppl):abstr 1585","journal-title":"J Clin Oncol"},{"key":"3678_CR27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","volume":"100","author":"K Kalam","year":"2014","unstructured":"Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100:1673\u20131680","journal-title":"Heart"},{"key":"3678_CR28","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","volume":"97","author":"SM Swain","year":"2003","unstructured":"Swain SM, Whaley FS, Ewer MS (2003) Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97:2869\u20132879","journal-title":"Cancer"},{"key":"3678_CR29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Hoff Von","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P et al (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710\u2013717","journal-title":"Ann Intern Med"},{"key":"3678_CR30","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/01.CIR.0000091080.57509.E9","volume":"108","author":"M Gulati","year":"2003","unstructured":"Gulati M, Pandey DK, Arnsdorf MF et al (2003) Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation 108:1554\u20131559","journal-title":"Circulation"},{"key":"3678_CR31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.282.16.1547","volume":"282","author":"M Wei","year":"1999","unstructured":"Wei M, Kampert JB, Barlow CE et al (1999) Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 282:1547\u20131553","journal-title":"JAMA"},{"key":"3678_CR32","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2011.39.9014","volume":"30","author":"LW Jones","year":"2012","unstructured":"Jones LW, Courneya KS, Mackey JR et al (2012) Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 30:2530\u20132537","journal-title":"J Clin Oncol"},{"key":"3678_CR33","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1634\/theoncologist.12-10-1156","volume":"12","author":"LW Jones","year":"2007","unstructured":"Jones LW, Haykowsky M, Pituskin EN et al (2007) Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor\u2013positive operable breast cancer. Oncologist 12:1156\u20131164","journal-title":"Oncologist"},{"key":"3678_CR34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.33549\/physiolres.932313","volume":"61","author":"M Lejskova","year":"2012","unstructured":"Lejskova M, Alusik S, Valenta Z, Adamkova S, Pitha J (2012) Natural postmenopause is associated with an increase in combined cardiovascular risk factors. Physiol Res 61:587\u2013596","journal-title":"Physiol Res"},{"key":"3678_CR35","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02474264 Accessed 19 Nov 2015"},{"key":"3678_CR36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/15246090050147745","volume":"9","author":"CN Bairey Merz","year":"2000","unstructured":"Bairey Merz CN, Olson M, McGorray S et al (2000) Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study. J Womens Health Gend Based Med 9:769\u2013777","journal-title":"J Womens Health Gend Based Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3678-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3678-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3678-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T19:47:59Z","timestamp":1600026479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3678-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3678"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3678-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}